ENST00000445409.7:c.1189G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000445409.7(OAS1):​c.1189G>A​(p.Gly397Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.676 in 1,607,450 control chromosomes in the GnomAD database, including 372,892 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43967 hom., cov: 30)
Exomes 𝑓: 0.67 ( 328925 hom. )

Consequence

OAS1
ENST00000445409.7 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.747

Publications

119 publications found
Variant links:
Genes affected
OAS1 (HGNC:8086): (2'-5'-oligoadenylate synthetase 1) This interferon-induced gene encodes a protein that synthesizes 2',5'-oligoadenylates (2-5As). This protein plays a key role in innate cellular antiviral response, and has been implicated in other cellular processes like cell growth and apoptosis. Alternative splicing results in multiple transcript variants with different enzymatic activities. Polymorphisms in this gene have been associated with susceptibility to viral infection, including SARS-CoV-2, and diabetes mellitus, type 1. This gene is located in a cluster of related genes on chromosome 12. [provided by RefSeq, May 2022]
OAS1 Gene-Disease associations (from GenCC):
  • pulmonary alveolar proteinosis with hypogammaglobulinemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.122781E-7).
BP6
Variant 12-112919637-G-A is Benign according to our data. Variant chr12-112919637-G-A is described in ClinVar as Benign. ClinVar VariationId is 1246789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.922 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OAS1NM_016816.4 linkc.*84G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000202917.10 NP_058132.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OAS1ENST00000202917.10 linkc.*84G>A 3_prime_UTR_variant Exon 6 of 6 1 NM_016816.4 ENSP00000202917.5

Frequencies

GnomAD3 genomes
AF:
0.750
AC:
113947
AN:
151954
Hom.:
43901
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.930
Gnomad AMI
AF:
0.684
Gnomad AMR
AF:
0.767
Gnomad ASJ
AF:
0.501
Gnomad EAS
AF:
0.774
Gnomad SAS
AF:
0.709
Gnomad FIN
AF:
0.729
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.657
Gnomad OTH
AF:
0.705
GnomAD2 exomes
AF:
0.715
AC:
168981
AN:
236406
AF XY:
0.705
show subpopulations
Gnomad AFR exome
AF:
0.936
Gnomad AMR exome
AF:
0.827
Gnomad ASJ exome
AF:
0.505
Gnomad EAS exome
AF:
0.786
Gnomad FIN exome
AF:
0.737
Gnomad NFE exome
AF:
0.659
Gnomad OTH exome
AF:
0.671
GnomAD4 exome
AF:
0.669
AC:
973286
AN:
1455378
Hom.:
328925
Cov.:
67
AF XY:
0.668
AC XY:
483098
AN XY:
723296
show subpopulations
African (AFR)
AF:
0.941
AC:
31387
AN:
33356
American (AMR)
AF:
0.819
AC:
35683
AN:
43560
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
13244
AN:
25890
East Asian (EAS)
AF:
0.796
AC:
31412
AN:
39472
South Asian (SAS)
AF:
0.692
AC:
59212
AN:
85524
European-Finnish (FIN)
AF:
0.730
AC:
38727
AN:
53068
Middle Eastern (MID)
AF:
0.581
AC:
3346
AN:
5760
European-Non Finnish (NFE)
AF:
0.650
AC:
720303
AN:
1108620
Other (OTH)
AF:
0.665
AC:
39972
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
19086
38171
57257
76342
95428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18994
37988
56982
75976
94970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.750
AC:
114077
AN:
152072
Hom.:
43967
Cov.:
30
AF XY:
0.753
AC XY:
55945
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.930
AC:
38600
AN:
41508
American (AMR)
AF:
0.767
AC:
11729
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.501
AC:
1737
AN:
3470
East Asian (EAS)
AF:
0.774
AC:
3982
AN:
5144
South Asian (SAS)
AF:
0.709
AC:
3405
AN:
4800
European-Finnish (FIN)
AF:
0.729
AC:
7707
AN:
10576
Middle Eastern (MID)
AF:
0.585
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
0.657
AC:
44625
AN:
67966
Other (OTH)
AF:
0.708
AC:
1498
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1299
2597
3896
5194
6493
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.677
Hom.:
148881
Bravo
AF:
0.763
TwinsUK
AF:
0.645
AC:
2391
ALSPAC
AF:
0.660
AC:
2545
ESP6500AA
AF:
0.923
AC:
4067
ESP6500EA
AF:
0.646
AC:
5555
ExAC
AF:
0.709
AC:
85510
Asia WGS
AF:
0.767
AC:
2666
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21638280) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied by a panel of primary immunodeficiencies. Number of patients: 89. Only high quality variants are reported. -

OAS1-related disorder Benign:1
May 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.9
DANN
Benign
0.51
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.32
T
MetaRNN
Benign
9.1e-7
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.75
PROVEAN
Benign
0.25
N
REVEL
Benign
0.052
Sift
Benign
0.85
T
Polyphen
0.075
B
Vest4
0.043
MutPred
0.29
Gain of sheet (P = 0.0125);
MPC
0.075
ClinPred
0.00056
T
GERP RS
0.60
gMVP
0.088
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2660; hg19: chr12-113357442; COSMIC: COSV52534024; COSMIC: COSV52534024; API